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Abstract A new non-invasive continuous cardiac output
(esCCO) monitoring system solely utilizing a routine car-
diovascular monitor was developed, even though a refer-
ence cardiac output (CO) is consistently required.
Subsequently, a non-invasive patient information CO cal-
ibration together with a new automated exclusion algo-
rithm was implemented in the esCCO system. We
evaluated the accuracy and trending ability of the new
esCCO system. Either operative or postoperative data of a
multicenter study in Japan for evaluation of the accuracy of
the original version of esCCO system were used to develop
the new esCCO system. A total of 207 patients, mostly
cardiac surgical patients, were enrolled in the study. Data
were manually reviewed to formulate a new automated
exclusion algorithm with enhanced accuracy. Then, a new
esCCO system based on a patient information calibration
together with the automated exclusion algorithm was
developed. CO measured with a new esCCO system was
compared with the corresponding intermittent bolus ther-
modilution CO (ICO) utilizing statistical methods includ-
ing polar plots analysis. A total of 465 sets of CO data
obtained using the new esCCO system were evaluated. The
difference in the CO value between the new esCCO and
ICO was 0.34 ± 1.50 (SD) L/min (95 % confidence limits
of -2.60 to 3.28 L/min). The percentage error was 69.6 %.
Polar plots analysis showed that the mean polar angle was
-1.6 and radial limits of agreement were ±53.3. This
study demonstrates that the patient information calibration
is clinically useful as ICO, but trending ability of the new
esCCO system is not clinically acceptable as judged by
percentage error and polar plots analysis, even though it’s
trending ability is comparable with currently available
arterial waveform analysis methods.
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1 Introduction
Continuous cardiac output (CCO) measurement calculated
by a thermodilution method (CCOpa) utilizing pulmonary
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artery catheter measurements is being used to optimize
cardiovascular management of critically ill patients.
However, it would be clinically useful to measure CCO
solely using routine cardiovascular monitors, without any
need for further sensors or procedures. A novel non-inva-
sive continuous cardiac output (esCCO) measurement
method solely utilizing the routine clinical monitor, based
on pulse contour analysis combined with pulse wave transit
time (PWTT) was devised by Sugo et al. [1], and this
method was demonstrated to have the potential to give rise
to an alternative non-invasive cardiac output (CO) trend for
post-cardiac surgical patients without apparent arrhythmia
[2]. PWTT is the sum of pre-ejection period (PEP) and
pulse wave arrival time from the ascending aorta to the
peripheral pulse oximetry (SpO2) probe site, and its chan-
ges have been reported to predict changes in blood pressure
[3]. PWTT is calculated from the interval between R wave
of ECG and peripheral SpO2 pulse wave arrival when ECG
and SpO2 are simultaneously recorded. A multicenter study
involving seven university hospitals in Japan was per-
formed to test the accuracy of this method, mostly during
and after cardiac surgery, including off-pump coronary
artery bypass grafting [4]. The results of the multicenter
study were comparable with those of the previous study
[2], supporting the clinical relevance of this method not
only in the ICU, but also during surgical procedures.
Thereafter, an automated exclusion algorithm for the
esCCO system was further developed to promote the reli-
ability of the measurement, even though its limitations
became evident during some surgical procedures, such as
cardiopulmonary bypass (CPB). Furthermore, as the esC-
CO system consistently requires a reference CO at the start
of measurement, a non-invasive CO derived from patient
demographic data and conventional cardiovascular vari-
ables was developed. We examined whether the new
esCCO system based on a patient information calibration
together with a new automated exclusion algorithm would
have acceptable trending ability.
2 Methods
Data of a multicenter study involving seven university
hospitals in Japan for evaluation of the accuracy of the
original version of esCCO system [4] were used to develop
the new esCCO system. The study was conducted with the
approval of the institutional review board of each of the
participating institutions, and with written informed con-
sent from each patient obtained before the surgery. Patients
with significant tricuspid valve insufficiency were excluded
from the study, as a high degree of tricuspid regurgitation
can cause underestimation of the thermodilution CO [5]. A
total of 213 patients were initially enrolled in the study. Six
patients with incomplete datasets were excluded from the
study. Most were cardiac surgical patients who had com-
plete sets of cardiovascular data that did not indicate
continued arrhythmia. Among these, 133 patients were also
evaluated postoperatively in the intensive care unit (ICU),
and 74 patients were evaluated while undergoing anesthe-
sia and surgery in the operating room (Table 1). esCCO
was computed continuously using an ECG monitor, an
arterial pressure monitor, and a pulse oximetry monitor. A
balloon tipped flow-directed thermodilution pulmonary
artery catheter (Swan-Ganz CCOmbo CCO/SVO2, ref.
744HF75, Baxter Healthcare, Edwards Critical Care Divi-
sion, Irvine, CA, USA) was inserted before the start of
surgery after induction of anesthesia. Correct positioning
was confirmed by pressure tracing as well as chest radi-
ography. The catheter was connected to a CCOpa monitor
(Vigilance, Version 5.4, Baxter Healthcare, Irvine, CA,
Table 1 Patient characteristics
Age, Height, Body weight,
BSA, and Duration are
presented as mean ± standard
deviation. The CO range is
presented as minimum–
maximum
ICU intensive care unit, OR
operating room, BSA body
surface area, Duration duration
of measurement
Site ICU OR Total
No. of patients 133 74 207
Sex (m/f) 90/43 48/26 138/69
Age (years) 65.9 ± 11.2 64.0 ± 14.8 65.3 ± 12.6
Height (cm) 159.4 ± 9.9 160.9 ± 10.9 159.9 ± 10.3
Body weight (kg) 59.3 ± 13.0 58.7 ± 11.4 59.1 ± 12.5
BSA (m2) 1.60 ± 0.20 1.61 ± 0.19 1.61 ± 0.20
Duration (h) 36.4 ± 26.0 7.6 ± 2.9 26.1 ± 25.0








Abdominal aortic surgery (3)
Pancreatectomy (7)
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USA). Subsequently, both CCOpa and esCCO measure-
ments were started. As esCCO consistently requires a
reference CO value obtained utilizing another CO mea-
surement system, a corresponding intermittent bolus ther-
modilution CO (ICO) value was used as a reference when
relatively stable cardiovascular states were achieved soon
after admission to the ICU or after insertion of the catheter
before the start of surgery in the operating room. There-
after, esCCO was periodically compared with ICO either at
10 a.m. on subsequent postoperative days until discontin-
uation of the thermodilution method for CO measurement
in the ICU or at one-hour intervals after the first mea-
surement before the start of surgery until the end of surgery
in the operating room except during cardiopulmonary
bypass. The ICO was measured following a bolus injection
of 10 ml chilled isotonic saline (\8 C) through the in-
jectate port of the pulmonary artery catheter. Measure-
ments were performed in triplicate at random points in the
respiratory cycle. A variation of ±10 % within triplicate
measurements was defined as acceptable.
2.1 New automated exclusion algorithm
Prior to applying a patient information calibration, a new
automated exclusion algorithm was formulated to promote
the accuracy of the original version of the esCCO system.
A total of 587 paired sets of data of the multicenter study
were reviewed by one author (YS). Thereafter, a new
exclusion algorithm was developed from 542 datasets for
the heart rate, pulse pressure, esCCO, including PWTT,
and ICO, after 37 theoretically inadequate datasets col-
lected during the some surgical procedures such as CPB,
had been excluded as shown in Fig. 1.
2.2 Patient information calibration for esCCO
After confirming the adequacy of each measurement data,
the new esCCO system was developed using a patient
information CO calibration together with the new auto-
mated exclusion algorithm. Multiple regression analysis
was conducted to formulate the patient information CO
calibration using patient demographic data, including age,
gender, height, and body weight as well as blood pressure,
heart rate and PWTT at the corresponding time-points
(‘‘Appendix 1’’). The result was applied as the reference for
the new esCCO system, instead of ICO. Fifty-four patients
(28 patients from one institution (NDMC) seen from Sep-
tember 2007 to January 2008, and 26 patients selected
through multi-facility evaluation from November 2007 to
February 2008) served as the training set for use as the
reference for the new esCCO system. Both maximum and
minimum ICO data for each patient were used for the
multiple regression analysis.
Among the total of 213 patients undergoing multicenter
evaluation, 26 patients were recruited for the training set,
and six patients with incomplete sets of independent vari-
ables were excluded from the study. Consequently, the
remaining 181 patients served as the validation set.
2.3 Statistical analysis
Data are expressed as mean ± SD. Bland-Altman analysis
was used to compare the esCCO and ICO. Statistical
analysis using Bland-Altman analysis associated with
multiple measurements correction was also performed for
esCCO data applying the new exclusion algorithm com-
pared with ICO [6]. Regression analysis of both was also
performed. The percentage error was calculated as the ratio
of 2SD of the bias to the mean ICO and was considered
clinically acceptable if it was 30 % or less, as proposed by
Critchley and Critchley [7]. Furthermore, the trending
ability of changes in the esCCO system was assessed by
using the polar plots method proposed by Critchley et al.
[8, 9]. Changes in CO values were calculated by sub-
tracting the previous CO value from the current CO value.
When ICO is the reference method, they would recommend
an angular bias no greater than ±5 and radial limits
agreement no greater than ±30 for good trending ability.
Fig. 1 Data flow diagram of manual review and automated exclusion
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Statistically significant difference was considered at
p \ 0.05.
3 Results
3.1 Manual review and automated exclusion
Thirty-seven data during aortic cross clamping and during
construction of posterior wall grafts in off-pump coronary
artery bypass (OPCAB) as well as CPB were found to be
theoretically inadequate for esCCO measurement, due to
changes in the SpO2 and/or ECG waveforms. Thereafter,
either manual review or the new automated exclusion
algorithm was applied in the remaining 542 datasets. Eight
datasets were manually judged to be inadequate due to
erroneous R wave detection. One dataset obtained during
postoperative cardiac tamponade was also manually
excluded due to the abnormal relationship between the SV
and PWTT (the SV was 39.7 ml, and the PWTT, 199 ms
before cardiac tamponade, and the corresponding values
were 13.6 ml and 157 ms during the cardiac tamponade).
The difference between the original esCCO data following
manual review and the ICO was 0.08 ± 1.07 L/min, with a
linear correlation between the two CO measures (r = 0.82,
n = 533, p \ 0.01). The percentage error was 47.2 %.
The new automated exclusion algorithm judged ten
datasets including one dataset obtained during cardiac
tamponade as inadequate. The difference between the ori-
ginal esCCO together with the new exclusion algorithm
and the ICO was 0.06 ± 1.04 L/min, with a linear corre-
lation between the two (r = 0.82, n = 532, p \ 0.01)
(Fig. 2). The SD associated with multiple measurements
correction was 1.05L/min. The percentage error was
48.5 %. In the original esCCO system an angular bias using
polar plots was -1.8 and radial limits of agreement were
±53.3. Polar concordance rate at 30 was 76.2 %.
3.2 The new esCCO system based on the patient
information calibration
The difference between the new esCCO and ICO in the
validation study was 0.15 ± 1.47 L/min at the calibration
point, and 0.34 ± 1.50 L/min at the subsequent measure-
ment points. The SD associated with multiple measure-
ments correction was also 1.50 L/min. There was a linear
correlation between the two (r = 0.64, n = 181, p \ 0.01
for the former and r = 0.57, n = 465, p \ 0.01 for the
latter, respectively) (Fig. 3), and the percentage error was
69.6 %. In the new esCCO system the mean polar angle
was -1.6 and radial limits of agreement were ±53.3.
Polar concordance rate at 30 was 75.2 % (Fig. 4).
4 Discussion
Although data collected during the three surgical proce-
dures in which limitations of accurate measurement
became evident had been excluded before the development
of the new automated exclusion algorithm, the results of
this study suggest that the new automated exclusion algo-
rithm is as effective as a retrospective manual review, as
judged by the Bland-Altman plots and percentage error,
even though 26 CO data were excluded by the automated
exclusion algorithm in the new esCCO system, since its
threshold level was set lower compared to the original
esCCO system.
The reported percentage error from several studies for
CO in arterial waveform analysis using standard radial
artery catheterization (APCO) such as the FloTrac/Vigileo
monitor (Edwards Lifescience, Irvin, USA) is in the range
of approximately 35–60 % [10–12]. Considering a per-
centage error of 48.5 % for the original esCCO system with
the new automated exclusion algorithm, the original esC-
CO system with ICO calibration cannot be interchangeable
with ICO, but would be comparable with the FloTrac/
Vigileo monitor.
Fig. 2 Scatter plots between intermittent bolus cardiac output (ICO)
and estimated continuous cardiac output (esCCO) after implementa-
tion of the new automated exclusion algorithm (upper), along with
Bland-Altman plots (lower). Closed diamonds indicate adequate data
(n = 532). Open squares indicate inadequate data as judged by the
new exclusion algorithm (n = 10)
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Critchley et al. [8], however, have recently pointed out
problems of the analytical methods, including use of the
Bland-Altman plots and percentage error, since the mag-
nitude of the underlying CO change and the degree of
agreement are totally ignored. To overcome these problems
for assessment of its trending ability, the same authors have
proposed a new approach using polar plots analysis [8], and
have further developed the methodology and devised initial
guidelines for decision making on the performance of new
CO monitors [9]. When ICO is used as the reference
method, they would recommend an angular bias of no
greater than ±5 and radial limits of agreement of no
greater than ±30 for good trending ability. Either the
original or the new esCCO system had an angular bias was
less than 5, but radial limits were apparently greater than
±30, indicating that the calibration method of the esCCO
system is good, but the trending ability is poor.
The reported an angular bias and radial limits of
agreement for APCO using the FloTrac/Vigileo monitor
are the range of -33 to 8 for the former and of ±40 to 50
for the latter, respectively [9], suggesting that trending
ability of the new esCCO system is comparable with the
FloTrac/Vigileo monitor.
There would be several potentially undesirable mea-
surement conditions present for acceptable trending
ability in this study. Firstly, changes in the SpO2 probe site
and body position may occur during routine patient care
particularly in the ICU. These changes which were not
consistently recognized in data review process may have a
significant impact on PWTT values, and therefore trending
ability of esCCO system.
Secondly, the esCCO system may be relatively accurate
even in the presence of changes in the systemic vascular
resistance (SVR) [2, 3, 13]. However, the result of a recent
multicenter study showed that SVR slightly affected the
accuracy of the system [4]. Therefore, apparent changes of
SVR after the first CO calibration may have a significant
impact on esCCO values in some patients of this study.
Thirdly, it appears that inaccuracy of the esCCO system
can occur not only during CPB or aortic cross clamping,
but also after aortic cross declamping, after discontinuation
of cardiac pacing, or shortly after weaning from CPB, as
observed for APCO [14]. Kanazawa et al. [15] reported a
decrease in the aortic elasticity after CPB, associated with
an aortic-to-radial arterial pressure gradient. Although
precise pathophysiology of these inaccuracies remains
unclear, a decrease in the aortic elasticity would affect
either the PWTT or the peripheral pulse pressure, leading
to transient inaccuracy of the esCCO soon after the
weaning from CPB. Presumably, there would be additional
Fig. 3 Scatter plots between intermittent bolus cardiac output (ICO)
and estimated continuous cardiac output (esCCO) using a patient
information calibration together with a new automated exclusion
algorithm (upper); along with Bland-Altman plots (lower). Closed
diamonds indicate adequate data (n = 465). Open squares indicate
inadequate data judged by the new exclusion algorithm (n = 26)
Fig. 4 Polar plots showing the trending ability of the new esCCO
system. Half-circle polar plots are shown with data transformed to
positive directional data only (n = 230) without central zone data
(\0.5 L/min, n = 205). The distance from the center of the plot
represents the mean change in cardiac output. The angular bias is
-1.6. The dashed lines of ±53.3 represent the limits of agreement.
Polar concordance rate at 30 is 75.2 %
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inadequate esCCO data, even after some of them had been
excluded by the automated exclusion algorithm.
Lastly, sampling size of this study for polar plots anal-
ysis was the largest (230 inclusion points) when compared
with other studies of CO measurement methods described
in a report by Critchley et al [9]. Patients in this study were
recruited mostly from cardiac surgery, but also other var-
ious major surgery as described in Table 1. Therefore, the
heterogeneity of the patient population may affect the
result of this study at least partly.
Multiple regression analysis was performed to calculate
the patient information calibration as the reference for the
esCCO. The patient demographic data, heart rate, pulse
pressure, and PWTT were used for this purpose. Heart rate,
mean arterial pressure, and standard deviation of the arte-
rial pressure have a major impact on the determination of
APCO [16]. Additionally, the patient’s specific vascular
impedance and compliance calculated from the patient
demographic data, including age, sex, height and body
weight also plays a significant role in determining the CO
[10]. Furthermore, PWTT is added to calculate the patient
information calibration, since pulse wave velocity mea-
sured by the arterial pressure waveform at carotid and
radial arteries was inversely correlated with the stroke
volume divided by the pulse pressure [17]. The result of
polar plots analysis would support the usefulness of the
patient information calibration in the new esCCO system.
There are several limitations to this study, in addition to
undesirable measurement conditions described above as
well as theoretically inadequate data collection during the
ECG or pulse oximetry probe displacement, arrhythmias,
intra-aortic balloon pumping, and/or certain surgical pro-
cedures. When a wide QRS complex or a high T wave is
present, the present version of the esCCO system fails
consistent and accurate R wave detection. Therefore, fur-
ther amendment of the software is mandatory. In addition,
this study did not consistently take other unknown unde-
sirable conditions that may potentially exert influence into
consideration during the new esCCO measurement, since
this study was aimed at evaluating the new esCCO system
during routine patient care rather than in research-oriented
management. Clinical esCCO data during body position
change, increased intrathoracic pressure, volume loading
and apparent vasoconstrictive states are lacking, even
though such factors could easily influence peripheral arte-
rial pressure registration [10]. Therefore, further prospec-
tive studies of the esCCO system are required to test the
effectiveness of the esCCO system in cases involving dif-
ferent pathophysiologies.
In conclusion, this study demonstrates that limitations of
the esCCO system become evident during some cardiac
surgical procedures, that the patient information calibration
is clinically useful as ICO, but trending ability of the new
esCCO system is not clinically acceptable based on per-
centage error and polar plots analysis, even though its
trending ability is comparable with currently available
arterial waveform analysis methods.
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Appendix 1
Multiple regression analysis was conducted using SPSS II
for Windows ver.11.0.1 J (SPSS Inc. Chicago, IL, USA).
ICO was defined as a dependent variable, whereas heart
rate (HR), pulse pressure (PP), PWTT, age, gender, height,
weight, and body surface area (BSA) were defined as
independent variables. One to a maximum of 10 pairs of
each dependent variable were used to find out the best-fit
formula, and 7 types of formulae were prepared. For each
formula, the SSe (residual sum of squares), AIC (Akaike’s
information criterion), residual minimum and maximum
values, and standard deviation were checked, and finally
the following Formula (1) was obtained as a regression
formula that shows a stable model.
CO ¼ a þ b  Gender þ c  Age þ d  BSA
þ e  PWTT þ f  HR  PP ð11Þ
CO = cardiac output (L/min); Gender: male = 0,
female = 1; Age: years; BSA = body surface area (m2);
PWTT = pulse wave transit time (msec); HR = heart rate
(rpm); PP = pulse pressure (mmHg). These cardiovascular
variables are the values, respectively, at the calibration
point. a, b, c, d, e, and f are constants or coefficients
determined by conducting multiple regression analysis
using learning data.
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